# Arnab Chakravarti

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/arnab-chakravarti/

## Facts

| Field | Value |
| --- | --- |
| Citations | 9,932 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 52 |
| i10-index | 121 |
| Last Known Institution | The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute |
| OpenAlex ID | https://openalex.org/A5018381770 |
| ORCID iD | 0000-0002-5392-8721 |
| Works | 496 |

## Researcher papers

- [Mechanisms and therapeutic implications of hypermutation in gliomas](https://scholariq.org/papers/mechanisms-and-therapeutic-implications-of-hypermutation-in-gliomas/)
- [The Prognostic Significance of Phosphatidylinositol 3-Kinase Pathway Activation in Human Gliomas](https://scholariq.org/papers/the-prognostic-significance-of-phosphatidylinositol-3-kinase-pathway-activation/)
- [Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress](https://scholariq.org/papers/targeting-dgat1-ameliorates-glioblastoma-by-increasing-fat-catabolism-and/)
- [Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth](https://scholariq.org/papers/glucose-mediated-n-glycosylation-of-scap-is-essential-for-srebp-1-activation-and/)
- [Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis](https://scholariq.org/papers/inhibition-of-soat1-suppresses-glioblastoma-growth-via-blocking-srebp-1-mediated/)
- [Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer](https://scholariq.org/papers/targeting-srebp-1-driven-lipid-metabolism-to-treat-cancer/)
- [Quantitatively Determined Survivin Expression Levels Are of Prognostic Value in Human Gliomas](https://scholariq.org/papers/quantitatively-determined-survivin-expression-levels-are-of-prognostic-value-in/)
- [<i>NFKBIA</i> Deletion in Glioblastomas](https://scholariq.org/papers/i-nfkbia-i-deletion-in-glioblastomas/)
- [Results of Whole-Brain Radiation As Salvage of Methotrexate Failure for Immunocompetent Patients With Primary CNS Lymphoma](https://scholariq.org/papers/results-of-whole-brain-radiation-as-salvage-of-methotrexate-failure-for/)
- [Long-Term Follow-Up of Patients With Rectal Cancer Managed by Local Excision With and Without Adjuvant Irradiation](https://scholariq.org/papers/long-term-follow-up-of-patients-with-rectal-cancer-managed-by-local-excision/)
- [Caregiver burden by treatment and clinical characteristics of patients with glioblastoma](https://scholariq.org/papers/caregiver-burden-by-treatment-and-clinical-characteristics-of-patients-with/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)

## Researcher university

- [The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute](https://scholariq.org/institutions/the-ohio-state-university-comprehensive-cancer-center-arthur-g-james-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.